6th Jan 2012 16:29
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the interests of Directors, Persons Discharging Managerial Responsibility or Connected Persons in the Ordinary shares of GlaxoSmithKline plc in respect of the under-mentioned persons arising from the purchase of Ordinary shares at a price of 1478.363 pence per Ordinary share on 5 January 2012 as a result of the reinvestment of dividends paid on Ordinary Shares held in the GlaxoSmithKline ShareReward Plan ("the Plan").
Sir Andrew Witty | Acquisition of 7 Ordinary shares
|
Mr S M Bicknell | Acquisition of 7 Ordinary shares
|
Mr S Dingemans | Acquisition of 1 Ordinary share
|
Mr E J Gray | Acquisition of 7 Ordinary shares
|
Mr S A Hussain | Acquisition of 7 Ordinary shares
|
Dr D Pulman | Acquisition of 11 Ordinary shares
|
Mr D S Redfern | Acquisition of 7 Ordinary shares
|
Ms C Thomas | Acquisition of 7 Ordinary shares
|
Mr P C Thomson | Acquisition of 13 Ordinary shares
|
Dr P J T Vallance | Acquisition of 15 Ordinary shares |
Mrs V A Whyte | Acquisition of 27 Ordinary shares |
The Company and the above-mentioned persons were advised of this information on 6 January 2012.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
6 January 2012
Related Shares:
Glaxosmithkline